CYTO-TOXIC EFFECTS OF TENIPOSIDE COMBINED WITH CIS-DIAMMINE-DICHLOROPLATINUM-(II) ON THE INVITRO LEWIS LUNG-CARCINOMA MODEL - INFLUENCE OF THE TREATMENT SCHEDULE

被引：1

作者：

BLANCY, E

CANAL, P

BERG, D

BUGAT, R

机构：

[1] CTR CLAUDIUS REGAUD,DEPT CLIN BIOL,PHARMACOKINET UNIT,20-24 RUE PONT ST PIERRE,F-31052 TOULOUSE,FRANCE

[2] CTR CLAUDIUS REGAUD,RES GRP,F-31052 TOULOUSE,FRANCE

[3] CTR CLAUDIUS REGAUD,DEPT MED ONCOL,F-31052 TOULOUSE,FRANCE

[4] UNIV TOULOUSE 3,F-31062 TOULOUSE,FRANCE

来源：

FUNDAMENTAL & CLINICAL PHARMACOLOGY | 1989年 / 3卷 / 04期

关键词：

D O I：

10.1111/j.1472-8206.1989.tb00677.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：363 / 370

页数：8

共 34 条

[1] ROLE OF ETOPOSIDE-BASED CHEMOTHERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY OR RELAPSING GERM-CELL TUMORS [J].

BOSL, GJ ;

YAGODA, A ;

GOLBEY, RB ;

WHITMORE, W ;

HERR, H ;

SOGANI, P ;

MORSE, M ;

VOGELZANG, N ;

MACDONALD, G .

AMERICAN JOURNAL OF MEDICINE, 1985, 78 (03) :423-428

[2] STUDIES OF CROSS-RESISTANCE, SYNERGISTIC COMBINATIONS AND BLOCKING OF ACTIVITY OF PLATINUM DERIVATIVES [J].

BURCHENAL, JH ;

KALAHER, K ;

DEW, K ;

LOKYS, L ;

GALE, G .

BIOCHIMIE, 1978, 60 (09) :961-965

[3]

CHEN GL, 1984, J BIOL CHEM, V259, P9182

[4]

DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187

[5]

DURAND RE, 1987, CANCER TREAT REP, V71, P673

[6]

EPSTEIN RJ, 1988, LANCET, V1, P521

[7] THE EFFECT OF METHOTREXATE PRETREATMENT ON 5-FLUOROURACIL KINETICS IN SARCOMA-180 INVIVO [J].

HERRMANN, R ;

KUNZ, W ;

OSSWALD, H ;

RITTER, M ;

PORT, R .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1985, 21 (06) :753-758

[8] SYNERGISTIC ANTITUMOR-ACTIVITY OF VINCRISTINE AND VP-16-213 [J].

JACKSON, DV ;

LONG, TR ;

TRAHEY, TF ;

MORGAN, TM .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1984, 13 (03) :176-180

[9]

MABEL JA, 1979, P AM ASS CANCER RES

[10] INVITRO SYSTEMS FOR EVALUATION OF COMBINATION CHEMOTHERAPY [J].

MOMPARLER, RL .

PHARMACOLOGY & THERAPEUTICS, 1980, 8 (01) :21-35

← 1 2 3 4 →